लोड हो रहा है...

Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial

BACKGROUND: The PIROUETTE (PIRfenidOne in patients with heart failUre and preserved lEfT venTricular Ejection fraction) trial is designed to evaluate the efficacy and safety of the anti-fibrotic pirfenidone in patients with chronic heart failure and preserved ejection fraction (HFpEF) and myocardial...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cardiovasc Drugs Ther
मुख्य लेखकों: Lewis, Gavin A., Schelbert, Erik B., Naish, Josephine H., Bedson, Emma, Dodd, Susanna, Eccleson, Helen, Clayton, Dannii, Jimenez, Beatriz Duran, McDonagh, Theresa, Williams, Simon G., Cooper, Anne, Cunnington, Colin, Ahmed, Fozia Zahir, Viswesvaraiah, Rajavarma, Russell, Stuart, Neubauer, Stefan, Williamson, Paula R., Miller, Christopher A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer US 2019
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689029/
https://ncbi.nlm.nih.gov/pubmed/31069575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-019-06876-y
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!